ESC Premium Access

Natriuretic peptides added to clinical parameters predict two-year prognosis of patients with chronic heart with mid-range and reduced ejection fraction.

Congress Presentation

About the speaker

Professor Jindrich Spinar

St. Anne University Hospital Brno (FNUSA), Brno (Czechia)
1 presentation
0 follower

9 more presentations in this session

Effect of beta-blockers on mortality in heart failure with mid-range and preserved ejection fraction: a meta-analysis

Speaker: Associate Professor H. Fukuta (Nagoya, JP)


Comparative efficacy of renin-angiotensin aldosteron system modulators and angiotensin receptor neprilyzin inhibitor in chronic heart failure with reduced, mid-ranged and preserved ejection fraction

Speaker: Professor L. Tumasyan (Yerevan, AM)


The predictive value of global longitudinal strain in patients with heart failure mid-range ejection fraction

Speaker: Doctor C. Wei-Ting (Tainan, TW)


Change in left ventricular ejection fraction and outcome in heart failure patients with mid-range ejection fraction: from the HIJ-HF prospective study

Speaker: Doctor K. Tsukamoto (Tokyo, JP)


Rehospitalization burden in heart failure with mid-range ejection fraction and morbidity burden. Is it a distinct phenotype?

Speaker: Doctor E. Santas Olmeda (Valencia, ES)


Access the full session

Poster Session 4 - Heart failure treatment, HFpEF, HFmrEF

Speakers: Professor J. Spinar, Associate Professor H. Fukuta, Professor L. Tumasyan, Doctor C. Wei-Ting, Doctor K. Tsukamoto...

About the event


ESC Congress 2019

31 August - 4 September 2019

Sessions Presentations

ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb